CONDENSED CONSOLIDATED STATEMENTS OF CONVERTIBLE REDEEMABLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)
$ in Thousands |
Total |
Series C Preferred Stock |
Series B Preferred Stock |
Common Stock |
Additional Paid-In Capital |
Accumulated Other Comprehensive Loss |
Accumulated Deficit |
Treasury Stock, at cost |
| Beginning balance (in shares) at Dec. 31, 2024 |
|
|
|
95,784,903
|
|
|
|
|
|
| Beginning balance at Dec. 31, 2024 |
|
|
|
$ 207,470
|
|
|
|
|
|
| Ending balance (in shares) at Mar. 31, 2025 |
|
|
|
95,784,903
|
|
|
|
|
|
| Ending balance at Mar. 31, 2025 |
|
|
|
$ 207,470
|
|
|
|
|
|
| Beginning balance (in shares) at Dec. 31, 2024 |
|
|
|
|
4,890,575
|
|
|
|
|
| Beginning balance at Dec. 31, 2024 |
|
$ (8,263)
|
|
|
$ 5
|
$ 1,714,052
|
$ (18,068)
|
$ (1,474,268)
|
$ (229,984)
|
| Increase (Decrease) in Stockholders' Equity |
|
|
|
|
|
|
|
|
|
| Net loss |
|
(3,993)
|
|
|
|
|
|
(3,993)
|
|
| Series B convertible redeemable preferred stock dividends |
[1] |
(4,439)
|
|
|
|
|
|
(4,439)
|
|
| Restricted stock units distributed (in shares) |
|
|
|
|
22,511
|
|
|
|
|
| Amortization of stock-based compensation |
|
284
|
|
|
|
284
|
|
|
|
| Settlement of restricted stock unit liability |
|
314
|
|
|
|
314
|
|
|
|
| Foreign currency translation adjustment |
|
2,639
|
|
|
|
|
2,639
|
|
|
| Ending balance (in shares) at Mar. 31, 2025 |
|
|
|
|
4,913,086
|
|
|
|
|
| Ending balance at Mar. 31, 2025 |
|
(13,458)
|
|
|
$ 5
|
1,714,650
|
(15,429)
|
(1,482,700)
|
(229,984)
|
| Beginning balance (in shares) at Dec. 31, 2024 |
|
|
|
95,784,903
|
|
|
|
|
|
| Beginning balance at Dec. 31, 2024 |
|
|
|
$ 207,470
|
|
|
|
|
|
| Ending balance (in shares) at Jun. 30, 2025 |
|
|
|
95,784,903
|
|
|
|
|
|
| Ending balance at Jun. 30, 2025 |
|
|
|
$ 207,470
|
|
|
|
|
|
| Beginning balance (in shares) at Dec. 31, 2024 |
|
|
|
|
4,890,575
|
|
|
|
|
| Beginning balance at Dec. 31, 2024 |
|
(8,263)
|
|
|
$ 5
|
1,714,052
|
(18,068)
|
(1,474,268)
|
(229,984)
|
| Increase (Decrease) in Stockholders' Equity |
|
|
|
|
|
|
|
|
|
| Net loss |
|
(13,485)
|
|
|
|
|
|
|
|
| Foreign currency translation adjustment |
|
7,915
|
|
|
|
|
|
|
|
| Ending balance (in shares) at Jun. 30, 2025 |
|
|
|
|
5,014,780
|
|
|
|
|
| Ending balance at Jun. 30, 2025 |
|
(21,669)
|
|
|
$ 5
|
1,715,149
|
(10,153)
|
(1,496,686)
|
(229,984)
|
| Beginning balance (in shares) at Mar. 31, 2025 |
|
|
|
95,784,903
|
|
|
|
|
|
| Beginning balance at Mar. 31, 2025 |
|
|
|
$ 207,470
|
|
|
|
|
|
| Ending balance (in shares) at Jun. 30, 2025 |
|
|
|
95,784,903
|
|
|
|
|
|
| Ending balance at Jun. 30, 2025 |
|
|
|
$ 207,470
|
|
|
|
|
|
| Beginning balance (in shares) at Mar. 31, 2025 |
|
|
|
|
4,913,086
|
|
|
|
|
| Beginning balance at Mar. 31, 2025 |
|
(13,458)
|
|
|
$ 5
|
1,714,650
|
(15,429)
|
(1,482,700)
|
(229,984)
|
| Increase (Decrease) in Stockholders' Equity |
|
|
|
|
|
|
|
|
|
| Net loss |
|
(9,492)
|
|
|
|
|
|
(9,492)
|
|
| Series B convertible redeemable preferred stock dividends |
[1] |
(4,494)
|
|
|
|
|
|
(4,494)
|
|
| Restricted stock units distributed (in shares) |
|
|
|
|
102,420
|
|
|
|
|
| Payments for taxes related to net share settlement of equity awards (in shares) |
|
|
|
|
(726)
|
|
|
|
|
| Payments for taxes related to net share settlement of equity awards |
|
(3)
|
|
|
|
(3)
|
|
|
|
| Amortization of stock-based compensation |
|
502
|
|
|
|
502
|
|
|
|
| Foreign currency translation adjustment |
|
5,276
|
|
|
|
|
5,276
|
|
|
| Ending balance (in shares) at Jun. 30, 2025 |
|
|
|
|
5,014,780
|
|
|
|
|
| Ending balance at Jun. 30, 2025 |
|
(21,669)
|
|
|
$ 5
|
1,715,149
|
(10,153)
|
(1,496,686)
|
(229,984)
|
| Beginning balance (in shares) at Dec. 31, 2025 |
|
|
12,670,863
|
|
|
|
|
|
|
| Beginning balance at Dec. 31, 2025 |
|
$ 89,722
|
$ 89,722
|
|
|
|
|
|
|
| Increase (Decrease) in Temporary Equity [Roll Forward] |
|
|
|
|
|
|
|
|
|
| Adjustment to issuance costs for recapitalization transaction |
[1] |
|
$ (68)
|
|
|
|
|
|
|
| Ending balance (in shares) at Mar. 31, 2026 |
|
|
12,670,863
|
|
|
|
|
|
|
| Ending balance at Mar. 31, 2026 |
|
|
$ 89,654
|
|
|
|
|
|
|
| Beginning balance (in shares) at Dec. 31, 2025 |
|
14,876,139
|
|
|
14,876,139
|
|
|
|
|
| Beginning balance at Dec. 31, 2025 |
|
$ 111,439
|
|
|
$ 15
|
1,781,265
|
(9,862)
|
(1,429,995)
|
(229,984)
|
| Increase (Decrease) in Stockholders' Equity |
|
|
|
|
|
|
|
|
|
| Net loss |
|
(6,248)
|
|
|
|
|
|
(6,248)
|
|
| Adjustment to issuance costs for recapitalization transaction |
[1] |
(50)
|
|
|
|
(50)
|
|
|
|
| Restricted stock units distributed (in shares) |
|
|
|
|
147,375
|
|
|
|
|
| Amortization of stock-based compensation |
|
208
|
|
|
|
208
|
|
|
|
| Settlement of restricted stock unit liability |
|
1,586
|
|
|
|
1,586
|
|
|
|
| Foreign currency translation adjustment |
|
(1,941)
|
|
|
|
|
(1,941)
|
|
|
| Ending balance (in shares) at Mar. 31, 2026 |
|
|
|
|
15,023,514
|
|
|
|
|
| Ending balance at Mar. 31, 2026 |
|
104,994
|
|
|
$ 15
|
1,783,009
|
(11,803)
|
(1,436,243)
|
(229,984)
|
| Beginning balance (in shares) at Dec. 31, 2025 |
|
|
12,670,863
|
|
|
|
|
|
|
| Beginning balance at Dec. 31, 2025 |
|
89,722
|
$ 89,722
|
|
|
|
|
|
|
| Ending balance (in shares) at Jun. 30, 2026 |
|
|
12,670,863
|
|
|
|
|
|
|
| Ending balance at Jun. 30, 2026 |
|
$ 89,654
|
$ 89,654
|
|
|
|
|
|
|
| Beginning balance (in shares) at Dec. 31, 2025 |
|
14,876,139
|
|
|
14,876,139
|
|
|
|
|
| Beginning balance at Dec. 31, 2025 |
|
$ 111,439
|
|
|
$ 15
|
1,781,265
|
(9,862)
|
(1,429,995)
|
(229,984)
|
| Increase (Decrease) in Stockholders' Equity |
|
|
|
|
|
|
|
|
|
| Net loss |
|
(21,033)
|
|
|
|
|
|
|
|
| Foreign currency translation adjustment |
|
$ (2,489)
|
|
|
|
|
|
|
|
| Ending balance (in shares) at Jun. 30, 2026 |
|
15,184,326
|
|
|
15,184,326
|
|
|
|
|
| Ending balance at Jun. 30, 2026 |
|
$ 89,468
|
|
|
$ 15
|
1,783,261
|
(12,796)
|
(1,451,028)
|
(229,984)
|
| Beginning balance (in shares) at Mar. 31, 2026 |
|
|
12,670,863
|
|
|
|
|
|
|
| Beginning balance at Mar. 31, 2026 |
|
|
$ 89,654
|
|
|
|
|
|
|
| Ending balance (in shares) at Jun. 30, 2026 |
|
|
12,670,863
|
|
|
|
|
|
|
| Ending balance at Jun. 30, 2026 |
|
89,654
|
$ 89,654
|
|
|
|
|
|
|
| Beginning balance (in shares) at Mar. 31, 2026 |
|
|
|
|
15,023,514
|
|
|
|
|
| Beginning balance at Mar. 31, 2026 |
|
104,994
|
|
|
$ 15
|
1,783,009
|
(11,803)
|
(1,436,243)
|
(229,984)
|
| Increase (Decrease) in Stockholders' Equity |
|
|
|
|
|
|
|
|
|
| Net loss |
|
(14,785)
|
|
|
|
|
|
(14,785)
|
|
| Restricted stock units distributed (in shares) |
|
|
|
|
161,821
|
|
|
|
|
| Payments for taxes related to net share settlement of equity awards (in shares) |
|
|
|
|
(1,009)
|
|
|
|
|
| Payments for taxes related to net share settlement of equity awards |
|
(8)
|
|
|
|
(8)
|
|
|
|
| Amortization of stock-based compensation |
|
260
|
|
|
|
260
|
|
|
|
| Foreign currency translation adjustment |
|
(548)
|
|
|
|
|
(548)
|
|
|
| Reclassifications due to business divestiture |
|
$ (445)
|
|
|
|
|
(445)
|
|
|
| Ending balance (in shares) at Jun. 30, 2026 |
|
15,184,326
|
|
|
15,184,326
|
|
|
|
|
| Ending balance at Jun. 30, 2026 |
|
$ 89,468
|
|
|
$ 15
|
$ 1,783,261
|
$ (12,796)
|
$ (1,451,028)
|
$ (229,984)
|
|
|